Serum CCL17 distinguishes sarcoid uveitis from TB-uveitis and QFT-negative uveitis

Acta Ophthalmol. 2022 Nov;100(7):e1533-e1534. doi: 10.1111/aos.15093. Epub 2022 Jan 26.

Authors

Benjamin Schrijver¹, Rina La Distia Nora², Nicole M A Nagtzaam¹, Jan A M van Laar^{1

3}, P Martin van Hagen^{1

3}, Willem A Dik¹

Affiliations

¹ Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
² Department of Ophthalmology, Faculty of Medicine University of Indonesia and Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
³ Department of Internal Medicine, Section Allergy & Clinical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

PMID: 35080799
DOI: 10.1111/aos.15093

No abstract available

Publication types

Letter

MeSH terms

Chemokine CCL17
Humans
Sarcoidosis* / complications
Sarcoidosis* / diagnosis
Tuberculin Test
Tuberculosis, Ocular* / diagnosis
Tuberculosis, Ocular* / drug therapy
Uveitis* / diagnosis

Substances

CCL17 protein, human
Chemokine CCL17